E N D
1. Dr.MRR
2. Dr.MRR
3. Dr.MRR
4. Dr.MRR
5. Dr.MRR
6. Dr.MRR
7. Dr.MRR
8. Dr.MRR
9. Dr.MRR
10. Dr.MRR
12. Dr.MRR IMMUNE RESPONSE
13. Dr.MRR
14. Dr.MRR IMMUNE RESPONSE The immune response is specific.
The immune response has memory.
Primary response
Secondary response
15. Dr.MRR
16. Dr.MRR
17. Dr.MRR
18. Dr.MRR
19. Dr.MRR CELLULAR BASIS OF IMMUNE RESPONSE
20. Dr.MRR
21. Dr.MRR
22. Dr.MRR
23. Dr.MRR
24. Dr.MRR
25. Dr.MRR
27. Dr.MRR
28. Dr.MRR CHARACTERS OF AN ANTIGEN
Antigen (Ag): -- COMPLETE // HAPTEIN
A molecule which elicits a specific immune response when introduced into an animal.
More specifically, antigenic (immunogenic) substances are:
Generally large molecules (>10,000 daltons in molecular weight),
Structurally complex (proteins are usually antigenic),
Accessible (the immune system must be able to contact the molecule), and
Foreign (not recognizable as "self").
29. Dr.MRR
30. Dr.MRR
31. Dr.MRR Antibody (Ab):
A glycoprotein produced in response to an antigen that is specific for the antigen and binds to it via non-covalent interactions.
The term "immunoglobulin" is often used interchangeably with "antibody".
We will use the term "immunoglobulin" to describe any antibody, regardless of specificity, and the term "antibody" to describe an antigen-specific "immunoglobulin".
Immunoglobulins (Igs) come in different forms (IgA, IgD, IgE, IgG, IgM) that reflect their structure.
32. Dr.MRR
33. Dr.MRR ANTIBODY--Ig
34. Dr.MRR
35. Dr.MRR
36. Dr.MRR ISOTYPE / ALLOTYPE / IDIOTYPE ISOTYPE-- Antigenic features of a class of Ig.
Specificity -- determines the type of IR
ALLOTYPE— Antigenic variation in one Ig
Specificity among individuals – due to
genetic diversity.
IDIOTYPE – Unique antigenic determinant
Specificity on the Hypervariable region of
Ig.– takes part in immune
regulation.
37. Dr.MRR
38. Dr.MRR
39. Dr.MRR IMMUNOGLOBULIN GENES
40. Dr.MRR ISOTYPE SWITCHING Class Switching – Ig M Ig G
Results from sequential association of VH gene with different CH gene.
Ig produced as a result will have the same specificity as original Ig M
41. Dr.MRR ANTIBODY MEDIATED IMMUNITY
42. Dr.MRR
43. Dr.MRR
44. Dr.MRR
45. Dr.MRR
46. Dr.MRR
47. Dr.MRR
48. Dr.MRR
49. Dr.MRR COMPLEMENT SYSTEM COMPLEMENT CASCADE
CLASSICAL PATHWAY
ALTERNATE PATHWAY
BIOLOGICAL EFFECTS OF COMPLEMENT
50. Dr.MRR
51. Dr.MRR
52. Dr.MRR
53. Dr.MRR PHAGOCYTOSIS
54. Dr.MRR
55. Dr.MRR
56. Dr.MRR
57. Dr.MRR
58. Dr.MRR
59. Dr.MRR CELLMEDIATED IMMUNITY T-CELL MATURATION
T-CELL ACTIVATION
CLUSTER DIFFERENTIATION- CD4 & CD8
FUNCTIONS OF T-CELLS –
EFFECTOR /REGULATOR
NK CELLS
K CELLS
60. Dr.MRR
61. Dr.MRR
62. Dr.MRR
63. Dr.MRR
64. Dr.MRR
65. Dr.MRR
66. Dr.MRR
67. Dr.MRR MAJOR HISTOCOMPATIBILITY COMPLEX – HLA SYSTEM MHC class I locus
Major Antigens HLA A 767 HLA B 1,178 HLA C 439 Minor Antigens HLA E 9 HLA F 21 HLA G 43
MHC class II
HLA -A1 -B1 -B3 to -B51
69. MAJOR HISTOCOMPATIBILITY COMPLEX Dr.MRR
70. Dr.MRR
71. Dr.MRR
72. Dr.MRR
73. Dr.MRR
74. Dr.MRR Cross-immunity?
75. Dr.MRR EFFECTS OF IMMUNE RESPONSE IN VIVO ---- IMMUNE PROTECTION
DISEASE CAUSATION
( HS & AI )
IN VITRO -- Ag-Ab REACTIONS ---
SEROLOGICAL TESTS --
DIAGNOSTIC IN INFECTIVE
AS WELL AS
IMMUNOLOGICAL DISEASES
76. Dr.MRR IMMUNE ABNORMALITIES HYPERSENSITIVITY
AUTOIMMUNITY
IMMUNODEFICIENCY DISEASES
77. Dr.MRR
78. Dr.MRR
79. Dr.MRR TUMOUR AND TRANSPLANTATION IMMUNITY MAINLY CMI
AMI ALSO PLAYS A ROLE ---
through ADCC &
afferent inhibition
80. Dr.MRR VACCINES LIVE VACCINES
KILLED VACCINE
WHOLE CELL VACCINES
MICROBIAL PRODUCTS
SUBUNIT VACCINES
SYNTHETIC VACCINES
RECOMBINANT VACCINES.
81. Dr.MRR IMMUNITY IN INFECTIONS BACTERIAL – EXTRACELLULAR– AMI
INTRACELLULAR – CMI
VIRAL INFECTIONS – CMI – PROTECTIVE
AMI- DIAGNOSTIC
PARASITIC INFECTIONS.
82. Dr.MRR IMMUNOLOGICAL BASIS OF DENTAL DISEASES. INFLAMMATORY PERIODONTAL DISEASES
-GINGIVITIS & PERIODONTITIS
-JUVENILE PERIODONTITIS
-GINGIVAL HYPERPLASIA
-ACUTE NECROTISING ULCERATIVE GINGIVITIS
83. Major Immunological features: Dental Plaque induces inflammation of surrounding tissue.
Local defence is not sufficient and Bacteria tend to furthur adhere to tooth surface– AMI & CMI both play role.
Complement Activation , Infiltration of leucocytes, Release of Enzymes and cytokenes and production of serous crevicular exudate
Bacterial virulance products and host immunological defences result in gingivitis and periodontitis.
Dr.MRR
84. APHTHOUS STOMATITIS. Lymphocytic infiltration present at the earliest stage of the disease.
Presence of circulating antibodies to oral mucosa in some persons which may crossreact with oral organisms.
Evidence of CMI to the same antigens.
Presence of circulating immune complexes in some patients.
Association with HLA –B 12
Favourable response to topical or systemic corticosteroids. Dr.MRR
85. Dr.MRR SYSTEMIC DISEASES WITH ORAL MANIFESTATIONS. AIDS
PEMPHIGUS
BENIGN PEMPHIGOID
CH.DISCOID L.E.
ERYTHEMA MULTIFORME
LICHEN PLANUS
INFLAMMATORY BOWEL DISEASES
SARCOIDOSIS
SJOGREN’S SYNDROME
SLE
RH. ARTHRITIS
PROGRESSIVE SYSTEMIC SCLEROSIS
86. Dr.MRR INFECTIONS HERPES SIMPLEX
MEASLES
CHICKENPOX
TREPONEMAL INFECTIONS
ORALCANDIDIASIS.
87. DENTURE STOMATITIS Inflammation of mucous membrane under the denture.
Associated with Candida inf. Which is associated with impaired CMI.
Trt. For candidiasis cures the problem. Dr.MRR
88. ORAL TUMOURS Leading cause of death in 3% of men and 1% of women.
Tobacco, Alcohol, CMI deficiency , and Viral infections (HSV&HPV) are found to predispose to oral malignancy.
Impaired CMI & Fall in Tcell counts is found in metastatic cancers. Dr.MRR
89. CMI response is found in oral leucoplakia
Fall in lymphocyte response to HSV is found to preceed the development of malignant
change in preexisting benign hyperkeratosis.
High levels of HSV-Ab in smokers suggests possibility of reactivation of HSV-I .– the viral genes probably induce transformation.
Patients with oral cancers have high HSV-I Ig-M suggesting a reactivation of infections
Dr.MRR
90. Dr.MRR